Veraliprid er kontraindiceret ved prolaktinafhængige tumorer som f. eks. prolaktinomer i hypofysen samt brystkræft.
Veralipride treatment is contra-indicated in patients with prolactin- dependent tumours such as pituitary gland prolactinoma and breast cancer.